May 6, 2026 7:52 AM
Faron Pharmaceuticals Limited (AIM:FARN), the clinical-stage immunotherapy company, has terminated its liquidity provision agreement with Lago Kapital Oy, with effect from 5 June. The Finnish company said it considers its share liquidity sufficient without additional support.
Faron Pharmaceuticals Limited (AIM:FARN), the clinical-stage immunotherapy company, has terminated its liquidity provision agreement with Lago Kapital Oy, with effect from 5 June. The Finnish company said it considers its share liquidity sufficient without additional support.
Comments
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy